Zhang J - Search Results

1

[Clinical significance of pathological response in the breast cancer after neoadjuvant chemotherapy].

Hui R, Zhang J, Fan Y. Hui R, et al. Among authors: zhang j. Zhonghua Yi Xue Za Zhi. 2008 Apr 8;88(14):961-4. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18756967 Chinese.

2

[Patterns and risk factors of recurrence in triple-negative breast cancer].

Yu F, Zhang X, Zhang S, Liu J, Liu Y, Zhang J. Yu F, et al. Among authors: zhang s, zhang j, zhang x. Zhonghua Yi Xue Za Zhi. 2014 Jul 22;94(28):2180-3. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25331467 Chinese.

3

[Prognostic analyses of occult breast cancer].

Hao X, Zhang S, Liu J, Zhang M, Zhang J. Hao X, et al. Among authors: zhang m, zhang s, zhang j. Zhonghua Yi Xue Za Zhi. 2014 Sep 30;94(36):2808-11. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25534096 Chinese.

4

[Prognostic significance of Ki-67 expression before and after neoadjuvant chemotherapy in different biological breast cancer phenotypes].

Liu Y, Zhang X, Yu F, Liu J, Zhang M, Zhang S, Hao X, Zhang J. Liu Y, et al. Among authors: zhang m, zhang s, zhang j, zhang x. Zhonghua Zhong Liu Za Zhi. 2014 Sep;36(9):671-6. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25564057 Chinese.

5

[Protective effect of dexrazoxane on cardiotoxicity in breast cancer patients who received anthracycline-containing chemotherapy].

Wang P, Zhang S, Zhang XB, Li WJ, Hao XM, Zhang J. Wang P, et al. Among authors: zhang xb, zhang s, zhang j. Zhonghua Zhong Liu Za Zhi. 2013 Feb;35(2):135-9. doi: 10.3760/cma.j.issn.0253-3766.2013.02.013. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23714670 Clinical Trial. Chinese.

6

[Clinicopathological features and prognosis of triple-negative breast cancer].

Li CY, Wang P, Zhang S, Liu Y, Zhang J. Li CY, et al. Among authors: zhang s, zhang j. Zhonghua Zhong Liu Za Zhi. 2013 Jun;35(6):463-7. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24119909 Chinese.

7

[Efficacy and safety analysis of paclitaxel liposome and docetaxel for the neoadjuvant chemotherapy of breast cancer].

Su W, Zhang S, Li C, Hao X, Zhang J. Su W, et al. Among authors: zhang s, zhang j. Zhonghua Zhong Liu Za Zhi. 2015 May;37(5):379-82. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 26463031 Chinese.

8

[Association between the expression of IGF1R and estrogen receptor and efficacy of neoadjuvant chemotherapy in beast cancer patients].

Liu L, Li X, Zhang J. Liu L, et al. Among authors: zhang j. Zhonghua Zhong Liu Za Zhi. 2015 Nov;37(11):833-6. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 26887513 Chinese.

9

A Phase II trial of Zoladex combined with CEF chemotherapy as neoadjuvant therapy in premenopausal women with hormone-responsive, operable breast cancer.

Zhang S, Zhang C, Liu J, Qin L, Cui S, Zhang J. Zhang S, et al. Among authors: zhang c, zhang j. Med Oncol. 2012 Jun;29(2):479-85. doi: 10.1007/s12032-011-9883-2. Epub 2011 Mar 6. Med Oncol. 2012. PMID: 21380781 Clinical Trial.

10

Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.

Hou G, Zhang S, Zhang X, Wang P, Hao X, Zhang J. Hou G, et al. Among authors: zhang s, zhang j, zhang x. Breast Cancer Res Treat. 2013 Feb;137(3):807-16. doi: 10.1007/s10549-012-2404-y. Epub 2013 Jan 6. Breast Cancer Res Treat. 2013. PMID: 23292119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178,604 results

Search Page

Filters